218 related articles for article (PubMed ID: 16163108)
1. Efficacy and safety of polyacrylamide hydrogel for facial soft-tissue augmentation.
von Buelow S; von Heimburg D; Pallua N
Plast Reconstr Surg; 2005 Sep; 116(4):1137-46; discussion 1147-8. PubMed ID: 16163108
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of polyacrylamide hydrogel for facial soft-tissue augmentation in a 2-year follow-up: a prospective multicenter study for evaluation of safety and aesthetic results in 101 patients.
von Buelow S; Pallua N
Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):85S-91S. PubMed ID: 16936548
[TBL] [Abstract][Full Text] [Related]
3. A 5-year assessment of safety and aesthetic results after facial soft-tissue augmentation with polyacrylamide hydrogel (Aquamid): a prospective multicenter study of 251 patients.
Pallua N; Wolter TP
Plast Reconstr Surg; 2010 Jun; 125(6):1797-1804. PubMed ID: 20517105
[TBL] [Abstract][Full Text] [Related]
4. Adverse reactions to injectable soft tissue permanent fillers.
Christensen L; Breiting V; Janssen M; Vuust J; Hogdall E
Aesthetic Plast Surg; 2005; 29(1):34-48. PubMed ID: 15759096
[TBL] [Abstract][Full Text] [Related]
5. Experiences with a new nonbiodegradable hydrogel (Aquamid): a pilot study.
de Cássia Novaes W; Berg A
Aesthetic Plast Surg; 2003; 27(5):376-80. PubMed ID: 14612994
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of polyacrylamide hydrogel injection in the treatment of human immunodeficiency virus-related facial lipoatrophy: a 5-year follow-up.
De Santis G; Pignatti M; Baccarani A; Pedone A; Spaggiari A; Orlando G; Guaraldi G
Plast Reconstr Surg; 2012 Jan; 129(1):101-109. PubMed ID: 22186503
[TBL] [Abstract][Full Text] [Related]
7. Four-year safety with polyacrylamide hydrogel to correct antiretroviral-related facial lipoatrophy.
Negredo E; Puig J; Aldea D; Medina M; Estany C; Pérez-Alvarez N; Rodríguez-Fumaz C; Muñoz-Moreno JA; Higueras C; Gonzalez-Mestre V; Clotet B
AIDS Res Hum Retroviruses; 2009 Apr; 25(4):451-5. PubMed ID: 19320569
[TBL] [Abstract][Full Text] [Related]
8. Prospective multicenter study for evaluation of safety, efficacy, and esthetic results of cross-linked polyacrylamide hydrogel in 81 patients.
Wolters M; Lampe H
Dermatol Surg; 2009 Feb; 35 Suppl 1():338-43. PubMed ID: 19207323
[TBL] [Abstract][Full Text] [Related]
9. Foreign body reaction due to skin filler: a case report.
Kawamura JY; Domaneschi C; Migliari DA; Sousa SO
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):469-71. PubMed ID: 16545711
[TBL] [Abstract][Full Text] [Related]
10. Complications of polyacrylamide hydrogel (PAAG) injection in facial augmentation.
Liu HL; Cheung WY
J Plast Reconstr Aesthet Surg; 2010 Jan; 63(1):e9-12. PubMed ID: 19540824
[TBL] [Abstract][Full Text] [Related]
11. Ten-Year Safety with Polyacrylamide Gel Used to Correct Facial Lipoatrophy in HIV-Infected Patients.
Negredo E; Puig J; Ornelas A; Echeverría P; Bonjoch A; Estany C; Higueras C; Gonzalez-Mestre V; Clotet B
AIDS Res Hum Retroviruses; 2015 Aug; 31(8):817-21. PubMed ID: 25858612
[TBL] [Abstract][Full Text] [Related]
12. Complications from injectable polyacrylamide gel, a new nonbiodegradable soft tissue filler.
Amin SP; Marmur ES; Goldberg DJ
Dermatol Surg; 2004 Dec; 30(12 Pt 2):1507-9. PubMed ID: 15606826
[TBL] [Abstract][Full Text] [Related]
13. Complications after polyacrylamide hydrogel injection for facial soft-tissue augmentation in China: twenty-four cases and their surgical management.
Shen H; Lv Y; Xu JH; Hong XY; Zeng BW; Xiao W; Zheng LJ
Plast Reconstr Surg; 2012 Aug; 130(2):340e-348e. PubMed ID: 22842430
[TBL] [Abstract][Full Text] [Related]
14. Polyacrylamide gel in cosmetic procedures: experience with Aquamid.
Patrick T
Semin Cutan Med Surg; 2004 Dec; 23(4):233-5. PubMed ID: 15745231
[TBL] [Abstract][Full Text] [Related]
15. Complications after polyacrylamide hydrogel injection for soft-tissue augmentation.
Ono S; Ogawa R; Hyakusoku H
Plast Reconstr Surg; 2010 Oct; 126(4):1349-1357. PubMed ID: 20885258
[TBL] [Abstract][Full Text] [Related]
16. Comparison between lipofilling and a nonabsorbable filler for facial wasting rehabilitation in HIV-positive patients.
Rauso R; Curinga G; Santillo V; Corvo G; Tartaro G
J Craniofac Surg; 2011 Sep; 22(5):1684-8. PubMed ID: 21959413
[TBL] [Abstract][Full Text] [Related]
17. Polyacrylamide hydrogel injection in the management of human immunodeficiency virus-related facial lipoatrophy: a 2-year clinical experience.
De Santis G; Jacob V; Baccarani A; Pedone A; Pinelli M; Spaggiari A; Guaraldi G
Plast Reconstr Surg; 2008 Feb; 121(2):644-653. PubMed ID: 18300986
[TBL] [Abstract][Full Text] [Related]
18. 5-year study of a polyacrylamide hydrogel-based filler for rehabilitation of HIV-related facial lipoatrophy.
Rauso R
Aesthet Surg J; 2015 Nov; 35(8):1021-9. PubMed ID: 25953480
[TBL] [Abstract][Full Text] [Related]
19. Polyacrylamide gel for facial wasting rehabilitation: how many milliliters per session?
Rauso R; Gherardini G; Parlato V; Amore R; Tartaro G
Aesthetic Plast Surg; 2012 Feb; 36(1):174-9. PubMed ID: 21638162
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of polyacrylamide hydrogel on human breast tissue.
Christensen LH; Breiting VB; Aasted A; Jørgensen A; Kebuladze I
Plast Reconstr Surg; 2003 May; 111(6):1883-90. PubMed ID: 12711948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
